Cite
HARVARD Citation
Danese, S. et al. (n.d.). A184 EARLY SYMPTOM CONTROL WITH MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN THE LUCENT-1 INDUCTION TRIAL. Journal of the Canadian Association of Gastroenterology. pp. 28-29. [Online].